EUVIMEDEUVIMED entdecken
Open Access

Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer

Gabriel Henrique Caxali, Laíza Brugnerotto, Mirian Carolini Esgoti Aal, Camila Ferreira Bannwart Castro, Flávia Karina Delella

Cancer Genomics - Proteomics · 2023

DOI: 10.21873/cgp.20400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2023. Verfasst von Gabriel Henrique Caxali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Structural and Functional Biology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, Brazil. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Pancreatic cancer (PC) has one of the highest mortality rates, with an overall five-year survival rate of only 7%. When diagnosed, PC is limited to the pancreas in only 20% of patients, whereas in 50% it has already metastasized. This is due to its late diagnosis, which makes the treatments used, such as radiotherapy, difficult, and reduces survival rates. Therefore, the importance of this study in detecting genes that may become possible biomarkers for this type of tumor, especially regarding the human secretome, is highlighted. These genes participate in pathways that are responsible for tumor migration and resistance to therapies, along with other important factors. MATERIALS AND METHODS: To achieve these goals, the following online tools and platforms have been expanded to discover and validate these biomarkers: The Human Protein Atlas database, the Xena Browser platform, Gene Expression Omnibus, the EnrichR platform and the Kaplan-Meier Plotter platform. RESULTS: Our study adopted a methodology that allows the identification of potential biomarkers related to the effectiveness of radiotherapy in PC. Inflammatory pathways were predominantly enriched, related to the regulation of biological processes, primarily in cytokine-derived proteins, which are responsible for tumor progression and other processes that contribute to the development of the disease. CONCLUSION: Radiotherapy treatment demonstrated greater efficacy when used in conjunction with other forms of therapy since it decreased the expression of essential genes involved in several inflammatory pathways linked to tumor progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorPancreatic NeoplasmsHumansPrognosisGene Expression Regulation, NeoplasticComputational BiologyGene Expression Profiling

Stichwörter der Autor:innen

Pancreatic cancerbioinformaticsbiomarkerradiotherapyresistancesecretome

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Structural and Functional Biology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, Brazil.
  • Molecular Genetics and Bioinformatics Laboratory - Experimental Research Unit, School of Medicine, São Paulo State University (UNESP), Botucatu, Brazil.
  • Department of Structural and Functional Biology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, Brazil; flavia.delella@unesp.br.

Zitieren

APA

Caxali, G. H., Brugnerotto, L., Aal, M. C. E., Castro, C. F. B., & Delella, F. K. (2023). Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20400

Vancouver

Caxali GH, Brugnerotto L, Aal MCE, Castro CFB, Delella FK. Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer. Cancer Genomics - Proteomics. 2023. doi:10.21873/cgp.20400

BibTeX
@article{Caxali2023,
  author = {Caxali, Gabriel Henrique and Brugnerotto, Laíza and Aal, Mirian Carolini Esgoti and Castro, Camila Ferreira Bannwart and Delella, Flávia Karina},
  title = {Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer},
  journal = {Cancer Genomics - Proteomics},
  year = {2023},
  doi = {10.21873/cgp.20400}
}
Kostenlos starten →